FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014718521> ?p ?o ?g. }

• W2014718521 endingPage "331" @default.
• W2014718521 startingPage "323" @default.
• W2014718521 abstract "Thymic malignancies, comprising thymoma and thymic carcinoma, are rare. Consequently, optimal chemotherapy for advanced thymic malignancies remains controversial. Platinum-based chemotherapy is currently the consensus treatment based on the results of single-arm phase II trials and retrospective investigations. However, comparison of cisplatin-based and carboplatin-based chemotherapy has yet to be undertaken; the effectiveness of the addition of anthracycline also remains uncertain. In the present study, clinical trials and retrospective data regarding platinum-based chemotherapy were analyzed. The endpoint was the response rate to each chemotherapy. For advanced thymoma, we compared platinum with anthracycline-based chemotherapy and platinum with non-anthracycline-based chemotherapy. For advanced thymic carcinoma, anthracycline-based versus non-anthracycline-based chemotherapy and carboplatin-based versus cisplatin-based chemotherapy were compared. This analysis included a retrospective study of response of advanced thymic carcinoma to irinotecan and cisplatin in our institution. The response rate for the 314 patients from 15 studies with advanced thymoma, including both prospective and retrospective data, was 69.4 % [95 % confidence interval (CI) 63.1–75.0 %] for platinum with anthracycline-based chemotherapy and 37.8 % (95 % CI 28.1–48.6 %; p < 0.0001) for platinum with non-anthracycline-based chemotherapy. The response rates after anthracycline-based and non-anthracycline-based chemotherapy for advanced thymic carcinoma were similar (41.8 vs. 40.9 %; p < 0.91), whereas the response rates after cisplatin-based and carboplatin-based chemotherapy for advanced thymic carcinoma differed significantly (53.6 vs. 32.8 %; p = 0.0029) in 206 patients from 10 studies. Platinum with anthracycline-based chemotherapy is an optimal combination for advanced thymoma. For advanced thymic carcinoma, cisplatin-based chemotherapy may be superior to carboplatin-based chemotherapy." @default.
• W2014718521 created "2016-06-24" @default.
• W2014718521 creator A5002845200 @default.
• W2014718521 creator A5011551950 @default.
• W2014718521 creator A5013301723 @default.
• W2014718521 creator A5054884728 @default.
• W2014718521 creator A5056456894 @default.
• W2014718521 date "2014-08-22" @default.
• W2014718521 modified "2023-10-05" @default.
• W2014718521 title "Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy" @default.
• W2014718521 cites W161686673 @default.
• W2014718521 cites W165982544 @default.
• W2014718521 cites W1909030710 @default.
• W2014718521 cites W1969770223 @default.
• W2014718521 cites W1975225467 @default.
• W2014718521 cites W1986361873 @default.
• W2014718521 cites W1989654748 @default.
• W2014718521 cites W1990948656 @default.
• W2014718521 cites W2014366678 @default.
• W2014718521 cites W2017968348 @default.
• W2014718521 cites W2022975447 @default.
• W2014718521 cites W2029883618 @default.
• W2014718521 cites W2030042098 @default.
• W2014718521 cites W2040926173 @default.
• W2014718521 cites W2052759126 @default.
• W2014718521 cites W2053244130 @default.
• W2014718521 cites W2053295326 @default.
• W2014718521 cites W2073683299 @default.
• W2014718521 cites W2074549036 @default.
• W2014718521 cites W2086115103 @default.
• W2014718521 cites W2090914388 @default.
• W2014718521 cites W2091075708 @default.
• W2014718521 cites W2092124969 @default.
• W2014718521 cites W2103642803 @default.
• W2014718521 cites W2108302629 @default.
• W2014718521 cites W2110654155 @default.
• W2014718521 cites W2125257681 @default.
• W2014718521 cites W2135479762 @default.
• W2014718521 cites W2150210290 @default.
• W2014718521 cites W2151090489 @default.
• W2014718521 cites W2165581959 @default.
• W2014718521 cites W2168071502 @default.
• W2014718521 cites W2262872618 @default.
• W2014718521 cites W2321860123 @default.
• W2014718521 cites W2405363761 @default.
• W2014718521 cites W2597835769 @default.
• W2014718521 cites W416132280 @default.
• W2014718521 cites W4239330499 @default.
• W2014718521 cites W4245199254 @default.
• W2014718521 cites W4247754872 @default.
• W2014718521 cites W8418572 @default.
• W2014718521 doi "https://doi.org/10.1007/s00432-014-1800-6" @default.
• W2014718521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4293490" @default.
• W2014718521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25146529" @default.
• W2014718521 hasPublicationYear "2014" @default.
• W2014718521 type Work @default.
• W2014718521 sameAs 2014718521 @default.
• W2014718521 citedByCount "58" @default.
• W2014718521 countsByYear W20147185212014 @default.
• W2014718521 countsByYear W20147185212015 @default.
• W2014718521 countsByYear W20147185212016 @default.
• W2014718521 countsByYear W20147185212017 @default.
• W2014718521 countsByYear W20147185212018 @default.
• W2014718521 countsByYear W20147185212019 @default.
• W2014718521 countsByYear W20147185212020 @default.
• W2014718521 countsByYear W20147185212021 @default.
• W2014718521 countsByYear W20147185212022 @default.
• W2014718521 countsByYear W20147185212023 @default.
• W2014718521 crossrefType "journal-article" @default.
• W2014718521 hasAuthorship W2014718521A5002845200 @default.
• W2014718521 hasAuthorship W2014718521A5011551950 @default.
• W2014718521 hasAuthorship W2014718521A5013301723 @default.
• W2014718521 hasAuthorship W2014718521A5054884728 @default.
• W2014718521 hasAuthorship W2014718521A5056456894 @default.
• W2014718521 hasBestOaLocation W20147185211 @default.
• W2014718521 hasConcept C121608353 @default.
• W2014718521 hasConcept C126322002 @default.
• W2014718521 hasConcept C141071460 @default.
• W2014718521 hasConcept C143998085 @default.
• W2014718521 hasConcept C2776349617 @default.
• W2014718521 hasConcept C2776694085 @default.
• W2014718521 hasConcept C2776802502 @default.
• W2014718521 hasConcept C2778239845 @default.
• W2014718521 hasConcept C2779159893 @default.
• W2014718521 hasConcept C2781451048 @default.
• W2014718521 hasConcept C530470458 @default.
• W2014718521 hasConcept C71924100 @default.
• W2014718521 hasConceptScore W2014718521C121608353 @default.
• W2014718521 hasConceptScore W2014718521C126322002 @default.
• W2014718521 hasConceptScore W2014718521C141071460 @default.
• W2014718521 hasConceptScore W2014718521C143998085 @default.
• W2014718521 hasConceptScore W2014718521C2776349617 @default.
• W2014718521 hasConceptScore W2014718521C2776694085 @default.
• W2014718521 hasConceptScore W2014718521C2776802502 @default.
• W2014718521 hasConceptScore W2014718521C2778239845 @default.
• W2014718521 hasConceptScore W2014718521C2779159893 @default.
• W2014718521 hasConceptScore W2014718521C2781451048 @default.
• W2014718521 hasConceptScore W2014718521C530470458 @default.

• next